ALC Stock Overview Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. More details
Rewards Risk Analysis See All Risk Checks Capture your thoughts, links and company narrative
Alcidion Group Limited Competitors Price History & Performance
Summary of share price highs, lows and changes for Alcidion Group Historical stock prices Current Share Price AU$0.068 52 Week High AU$0.09 52 Week Low AU$0.04 Beta 1.56 1 Month Change 11.48% 3 Month Change 30.77% 1 Year Change 38.78% 3 Year Change -72.24% 5 Year Change -69.78% Change since IPO 4.62%
Recent News & Updates
Alcidion Group Limited to Report Q2, 2025 Results on Jan 30, 2025 Jan 23
Forecast breakeven date pushed back to 2027 Dec 24
Alcidion Group Limited Announces Change of Company Secretary Oct 25
Insufficient new directors Oct 01
Alcidion Group Limited, Annual General Meeting, Oct 23, 2024 Sep 20
Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.003 loss in FY 2023) Aug 31 See more updates
Alcidion Group Limited to Report Q2, 2025 Results on Jan 30, 2025 Jan 23
Forecast breakeven date pushed back to 2027 Dec 24
Alcidion Group Limited Announces Change of Company Secretary Oct 25
Insufficient new directors Oct 01
Alcidion Group Limited, Annual General Meeting, Oct 23, 2024 Sep 20
Full year 2024 earnings released: AU$0.006 loss per share (vs AU$0.003 loss in FY 2023) Aug 31 Alcidion Group Limited Announces Board and Committee Changes Aug 29
Alcidion Group Limited to Report Fiscal Year 2024 Results on Aug 29, 2024 Aug 22
Alcidion Group Limited to Report Q4, 2024 Results on Jul 30, 2024 Jul 25
Forecast to breakeven in 2025 Jul 24
Alcidion Group Limited Provides Revenue Guidance for the Second Half of 2024 Apr 19
Alcidion Group Limited to Report Q3, 2024 Results on Apr 18, 2024 Apr 12
New minor risk - Profitability Mar 08
Alcidion Group Limited to Report First Half, 2024 Results on Feb 28, 2024 Feb 22
Alcidion Group Limited to Report Q2, 2024 Results on Jan 31, 2024 Jan 24
Alcidion Group Limited has completed a Follow-on Equity Offering in the amount of AUD 5.025 million. Nov 06
New minor risk - Shareholder dilution Nov 06 Alcidion Group Limited has filed a Follow-on Equity Offering in the amount of AUD 1 million. Nov 02
Alcidion Group Limited to Report Q1, 2024 Results on Oct 31, 2023 Oct 26
Alcidion Group Limited, Annual General Meeting, Nov 20, 2023 Oct 02
Now 22% undervalued Sep 01
Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in FY 2022) Aug 24
Alcidion Group Limited to Report Fiscal Year 2023 Results on Aug 24, 2023 Aug 18
Alcidion Group Limited to Report Q4, 2023 Results on Jul 27, 2023 Jul 22
Now 21% undervalued after recent price drop Jul 18
Independent Non-Executive Director recently bought AU$55k worth of stock May 09
Forecast breakeven date moved forward to 2023 Apr 29
Forecast breakeven date pushed back to 2024 Mar 01
First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.006 loss in 1H 2022) Feb 25
Alcidion Group Limited to Report First Half, 2023 Results on Feb 24, 2023 Feb 17
Alcidion Group Limited to Report First Half, 2023 Results on Jan 30, 2023 Jan 23
Alcidion Group Limited Announces Malcolm Pradhan Stepping Down as Executive Director and Chief Medical Officer Nov 02
Alcidion Group Limited to Report Q1, 2023 Results on Oct 31, 2022 Oct 26
Full year 2022 earnings released: AU$0.004 loss per share (vs AU$0.002 loss in FY 2021) Aug 31 Alcidion Group Limited, Annual General Meeting, Oct 25, 2022
Alcidion Group Limited to Report Fiscal Year 2022 Results on Aug 30, 2022 Aug 25
Alcidion Group Limited to Report Q4, 2022 Results on Jul 27, 2022 Jul 20
Forecast breakeven date pushed back to 2023 Apr 27
Alcidion Group Limited to Report Q3, 2022 Results on Apr 27, 2022 Apr 21
Forecast breakeven date pushed back to 2023 Mar 02
First half 2022 earnings: EPS in line with analyst expectations despite revenue beat Feb 26
Alcidion Group Limited to Report First Half, 2022 Results on Feb 23, 2022 Feb 16
Alcidion Group Limited (ASX:ALC) completed the acquisition of Silverlink Software Limited. Dec 16
Alcidion Group Limited (ASX:ALC) agreed to acquire Silverlink Software Limited for £33 million. Dec 07
Forecast to breakeven in 2022 Sep 23
Less than half of directors are independent Sep 12
Full year 2021 earnings released: AU$0.002 loss per share (vs AU$0.003 loss in FY 2020) Aug 25
Alcidion Group Limited Provides Earnings Guidance for the Fiscal 2022 Aug 24
Co-Founder & Non-Executive Director Raymond Blight has left the company Jul 13
Insider recently bought AU$3.9m worth of stock May 20
Alcidion Signs Contract with Te Manawa Taki DHBs for Electronic Medication Management Mar 04
First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020) Mar 02
New 90-day high: AU$0.26 Feb 20
Alcidion Group Limited to Report First Half, 2021 Results on Feb 25, 2021 Feb 18
New 90-day high: AU$0.21 Jan 21
Alcidion Group Limited to Report Q2, 2021 Results on Jan 27, 2021 Jan 20
Alcidion Group Limited Announces an Extension of its Contract with South Tees Hospitals NHS Foundation Trust Dec 16
Alcidion Group Limited Announces Reseller Agreement with Nextgate Solutions, Inc Nov 27
New 90-day high: AU$0.21 Nov 24
Alcidion Group Limited Signs $9.5 Million Deal with NHS Trust Nov 09
Alcidion Group Limited to Report Q1, 2021 Results on Oct 27, 2020 Oct 20
Insider recently bought AU$195k worth of stock Sep 30
Full year earnings released - AU$0.0033 loss per share Aug 28
Alcidion Group Limited to Report Fiscal Year 2020 Results on Aug 27, 2020 Aug 21 Shareholder Returns ALC AU Healthcare Services AU Market 7D 0% 2.1% 1.4% 1Y 38.8% 139.9% 9.2%
See full shareholder returns
Return vs Market: ALC exceeded the Australian Market which returned 10.3% over the past year.
Price Volatility Is ALC's price volatile compared to industry and market? ALC volatility ALC Average Weekly Movement 6.0% Healthcare Services Industry Average Movement 9.0% Market Average Movement 7.9% 10% most volatile stocks in AU Market 16.3% 10% least volatile stocks in AU Market 3.0%
Stable Share Price: ALC has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: ALC's weekly volatility (6%) has been stable over the past year.
About the Company Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a fast healthcare interoperability resource (FHIR)-events platform that integrates digital patient care services, such as a clinical decision support system, electronic patient record (EPR), and patient administration systems (PAS). Its platform also provides electronic patient flow journey boards; virtual care and remote patient management; integrated care system smart operations center; emergency department and specialized care; real-time data integration, FHIR-based interoperability, and predictive analytics; comprehensive health record for informed patient care; modern modular EPR; and streamlined clinical workflows, intelligent comms, and mobility solutions.
Show more Alcidion Group Limited Fundamentals Summary How do Alcidion Group's earnings and revenue compare to its market cap? ALC fundamental statistics Market cap AU$92.66m Earnings (TTM ) -AU$8.42m Revenue (TTM ) AU$37.06m
Earnings & Revenue Key profitability statistics from the latest earnings report (TTM) ALC income statement (TTM ) Revenue AU$37.06m Cost of Revenue AU$5.14m Gross Profit AU$31.92m Other Expenses AU$40.34m Earnings -AU$8.42m
Last Reported Earnings
Jun 30, 2024
Earnings per share (EPS) -0.0063 Gross Margin 86.14% Net Profit Margin -22.71% Debt/Equity Ratio 0%
How did ALC perform over the long term?
See historical performance and comparison
Company Analysis and Financial Data Status Data Last Updated (UTC time) Company Analysis 2025/01/31 08:10 End of Day Share Price 2025/01/31 00:00 Earnings 2024/06/30 Annual Earnings 2024/06/30
Data Sources The data used in our company analysis is from S&P Global Market Intelligence LLC . The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package Data Timeframe Example US Source * Company Financials 10 years Income statement Cash flow statement Balance sheet Analyst Consensus Estimates +3 years Forecast financials Analyst price targets Market Prices 30 years Stock prices Dividends, Splits and Actions Ownership 10 years Top shareholders Insider trading Management 10 years Leadership team Board of directors Key Developments 10 years
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here .
Analysis Model and Snowflake Details of the analysis model used to generate this report is available on our Github page , we also have guides on how to use our reports and tutorials on Youtube .
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources Alcidion Group Limited is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst Institution Elyse Shapiro Bell Potter Thomas Wakim Bell Potter Elyse Shapiro Canaccord Genuity
Show 2 more analysts 
